Taken together, these results suggest that the expression of PD-1/PD-L1 on DCs hinders the survival of DCs, reduces the production of proinflammatory cytokines, inhibits innate immunity, and reduces the antitumor effect of tumor-infiltrating T cells. Here, PDCD1 is linked to neoplasm.